cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.10060244
title: Metadata record for: Evaluating sequence data quality from the Swift Accel-Amplicon CFTR Panel

description: This dataset contains key characteristics about the data described in the Data Descriptor Evaluating sequence data quality from the Swift Accel-Amplicon CFTR Panel. <br> Contents: <br> 1. human readable metadata summary table in CSV format 2. machine readable metadata file in JSON format <br> <br> Versioning Note:Version 2 was generated when the metadata format was updated from JSON to JSON-LD. This was an automatic process that changed only the format, not the contents, of the metadata.<br>
DOI: 10.6084/m9.figshare.10060235
title: Appendix 1_PONE-D-19-19688.xls

description: Original population of uncomplicated monochorionic twins that was used for constructing MC twins specific longitudinal references for the following Doppler parameters: umbilical artery pulsatility index (UA-PI), middle cerebral artery (MCA) PI and peak systolic velocity (PSV) and ductus venosus (DV) PI.<br>
DOI: 10.6084/m9.figshare.10060241
title: Database of Bed Material Load Transport in Flumes and Rivers with Fine-grained Beds

description: This database is a compilation of sediment transport data collected from laboratory flumes and rivers. Bed material load is the part of the sediment load that is both being transported by water flow in the channel, and also is found in abundance on the channel bed surface. This database is focused on the fine-grained sediment transport where bed median grain size is less than 2 mm. Particular attention is paid to the data with bed median grain size less than 250 <i>µm</i>. The compiled database includes most of published data on equilibrium bed material transport with median grain size less than 250 <i>µm</i>. Sediment is transported at equilibrium when the water flow is steady and uniform and the flow does not, in the mean, erode or deposit sediment from or to the granular channel bed; thus there is no net erosion or deposition on the channel bed. Each complete set of data includes channel width, hydraulic parameters (water discharge, water surface slope, water depth and average flow velocity), sediment characteristics (median grain size, standard deviation, concentration), temperature and bedform states. In total, the database consists of 783 field and 811 flume data sets.
DOI: 10.6084/m9.figshare.10060202
title: SCIMITAR+ Trial: A randomised study within a trial (SWAT) of a contingent financial reward to improve trial follow-up - Data Set

description: Data relating to the SCIMITAR+ Trial Study within a Trial assessing effectiveness of a contingent £10 note on trial retention
DOI: 10.6084/m9.figshare.10060244.v2
title: Metadata record for: Evaluating sequence data quality from the Swift Accel-Amplicon CFTR Panel

description: This dataset contains key characteristics about the data described in the Data Descriptor Evaluating sequence data quality from the Swift Accel-Amplicon CFTR Panel. <br> Contents: <br> 1. human readable metadata summary table in CSV format 2. machine readable metadata file in JSON format <br> <br> Versioning Note:Version 2 was generated when the metadata format was updated from JSON to JSON-LD. This was an automatic process that changed only the format, not the contents, of the metadata.<br>
DOI: 10.6084/m9.figshare.10060244.v1
title: Metadata record for: Evaluating sequence data quality from the Swift Accel-Amplicon CFTR Panel

description: This dataset contains key characteristics about the data described in the Data Descriptor Evaluating sequence data quality from the Swift Accel-Amplicon CFTR Panel. <br> Contents: <br> 1. human readable metadata summary table in CSV format 2. machine readable metadata file in JSON format
DOI: 10.6084/m9.figshare.10060085
title: Body height and testosterone change

description: A positive relationship between body height and testosterone response to physical exercise<br> Marta Kowal<sup>1</sup>, Piotr Sorokowski<sup>1</sup>*, Agnieszka Żelaźniewicz<sup>2</sup>, Judyta Nowak<sup>2</sup>, Sylwester Orzechowski<sup>1</sup>, Grzegorz Żurek<sup>3</sup>, Alina Żurek<sup>1</sup>. <sup>1</sup>Institute of Psychology, University of Wrocław, Wrocław, Poland.<br> <sup>2</sup>Department of Human Biology, University of Wrocław, Wrocław, Poland.<br> <sup>3</sup>Wrocław Sports University, Wrocław, Poland.<b></b> <b>*Correspondence: <br> </b>Piotr Sorokowski<br> sorokowskipiotr@yahoo.co.uk
DOI: 10.6084/m9.figshare.10060202.v2
title: SCIMITAR+ Trial: A randomised study within a trial (SWAT) of a contingent financial reward to improve trial follow-up - Data Set

description: Data relating to the SCIMITAR+ Trial Study within a Trial assessing effectiveness of a contingent £10 note on trial retention
DOI: 10.6084/m9.figshare.10060202.v1
title: SCIMITAR+ Trial: A randomised study within a trial (SWAT) of a contingent financial reward to improve trial follow-up - Data Set

description: Data relating to the SCIMITAR+ Trial Study within a Trial assessing effectiveness of a contingent £10 note on trial retention
DOI: 10.6084/m9.figshare.10060046
title: KalsoomOrton Supplemental data

description: Data from experiments recording pure tone thresholds and intra-aural core temperatures in 16 young adults. Recordings were made between 9-10am and 4-5pm in each participant.
DOI: 10.6084/m9.figshare.10060064
title: Tutorial_LCMS

description: <b>METABOLIC PATHWAY ANALYSIS BY LIQUID CHROMATOGRAPHY (UHPLC) COUPLED TO HIGH RESOLUTION MASS SPECTROMETRY (LC/MS)</b>
DOI: 10.6084/m9.figshare.10060046.v1
title: KalsoomOrton Supplemental data

description: Data from experiments recording pure tone thresholds and intra-aural core temperatures in 16 young adults. Recordings were made between 9-10am and 4-5pm in each participant.
DOI: 10.6084/m9.figshare.10059896
title: Confocal Measurements of Cellular Distributions Data

description: Confocal Z-stack images of fluorescently tagged platelets. Original data is provided for all donors and scans. The data is in the original .oib format as well as python numpy arrays (.npy). An ipython jupyter notebook is included to highlight how to access and display the data. Edit the jupyter notebook to point to the correct data location.
DOI: 10.6084/m9.figshare.10059896.v1
title: Confocal Measurements of Cellular Distributions Data

description: Confocal Z-stack images of fluorescently tagged platelets. Original data is provided for all donors and scans. The data is in the original .oib format as well as python numpy arrays (.npy). An ipython jupyter notebook is included to highlight how to access and display the data. Edit the jupyter notebook to point to the correct data location.
DOI: 10.6084/m9.figshare.10059869
title: Supplementary Material for: Genome-Wide Analysis of the Nucleosome Landscape in Individuals with Coffin-Siris Syndrome

description: The switch/sucrose non-fermenting (SWI/SNF) complex is an ATP-dependent chromatin remodeller that regulates the spacing of nucleosomes and thereby controls gene expression. Heterozygous mutations in genes subunits of the SWI/SNF complex have been reported in individuals with Coffin-Siris syndrome (CSS), with the majority of the mutations in <i>ARID1B</i>. CSS is a rare congenital disorder characterized by facial dysmorphisms, digital anomalies, and variable intellectual disability. We hypothesized that mutations in genes encoding subunits of the ubiquitously expressed SWI/SNF complex may lead to alterations of the nucleosome profiles in different cell types. We performed the first study on CSS-patient samples and investigated the nucleosome landscapes of cell-free DNA (cfDNA) isolated from blood plasma by whole-genome sequencing. In addition, we studied the nucleosome landscapes of CD14<sup>+</sup> monocytes from CSS-affected individuals by nucleosome occupancy and methylome-sequencing (NOMe-seq) as well as their expression profiles. In cfDNA of CSS-affected individuals with heterozygous <i>ARID1B</i> mutations, we did not observe major changes in the nucleosome profile around transcription start sites. In CD14<sup>+</sup> monocytes, we found few genomic regions with different nucleosome occupancy when compared to controls. RNA-seq analysis of CD14<sup>+</sup> monocytes of these individuals detected only few differentially expressed genes, which were not in proximity to any of the identified differential nucleosome-depleted regions. In conclusion, we show that heterozygous mutations in the human SWI/SNF subunit ARID1B do not have a major impact on the nucleosome landscape or gene expression in blood cells….
DOI: 10.6084/m9.figshare.10059869.v1
title: Supplementary Material for: Genome-Wide Analysis of the Nucleosome Landscape in Individuals with Coffin-Siris Syndrome

description: The switch/sucrose non-fermenting (SWI/SNF) complex is an ATP-dependent chromatin remodeller that regulates the spacing of nucleosomes and thereby controls gene expression. Heterozygous mutations in genes subunits of the SWI/SNF complex have been reported in individuals with Coffin-Siris syndrome (CSS), with the majority of the mutations in <i>ARID1B</i>. CSS is a rare congenital disorder characterized by facial dysmorphisms, digital anomalies, and variable intellectual disability. We hypothesized that mutations in genes encoding subunits of the ubiquitously expressed SWI/SNF complex may lead to alterations of the nucleosome profiles in different cell types. We performed the first study on CSS-patient samples and investigated the nucleosome landscapes of cell-free DNA (cfDNA) isolated from blood plasma by whole-genome sequencing. In addition, we studied the nucleosome landscapes of CD14<sup>+</sup> monocytes from CSS-affected individuals by nucleosome occupancy and methylome-sequencing (NOMe-seq) as well as their expression profiles. In cfDNA of CSS-affected individuals with heterozygous <i>ARID1B</i> mutations, we did not observe major changes in the nucleosome profile around transcription start sites. In CD14<sup>+</sup> monocytes, we found few genomic regions with different nucleosome occupancy when compared to controls. RNA-seq analysis of CD14<sup>+</sup> monocytes of these individuals detected only few differentially expressed genes, which were not in proximity to any of the identified differential nucleosome-depleted regions. In conclusion, we show that heterozygous mutations in the human SWI/SNF subunit ARID1B do not have a major impact on the nucleosome landscape or gene expression in blood cells….
DOI: 10.6084/m9.figshare.10059710
title: Full data for identified metabolites in wild-type and amphotericin B-resistant Leishmania mexicana parasites.

description: Metabolites were identified and filtered as described in Materials & Methods. Confidence of identification is represented by Metabolomics Standards Initiative (MSI) level, with level two being identification by match to mass-to-charge (<i>m/z</i>) ratio alone, level one to <i>m/z</i> in addition to retention time match to an authentic standard. Metabolite category was annotated using the IDEOM pipeline. Metabolite intensities for individual replicates and mean values are shown, along with fold-changes compared to wild-type (red represents an increase, blue a decrease, yellow no change). Raw p-values are from ANOVA analysis of log-transformed intensities, q-values from Benjamini-Hochberg adjustment of these, and p-values for each line from Tukey’s Honest Significant Difference <i>post hoc</i> comparison to wild-type.
DOI: 10.6084/m9.figshare.10059710.v1
title: Full data for identified metabolites in wild-type and amphotericin B-resistant Leishmania mexicana parasites.

description: Metabolites were identified and filtered as described in Materials & Methods. Confidence of identification is represented by Metabolomics Standards Initiative (MSI) level, with level two being identification by match to mass-to-charge (<i>m/z</i>) ratio alone, level one to <i>m/z</i> in addition to retention time match to an authentic standard. Metabolite category was annotated using the IDEOM pipeline. Metabolite intensities for individual replicates and mean values are shown, along with fold-changes compared to wild-type (red represents an increase, blue a decrease, yellow no change). Raw p-values are from ANOVA analysis of log-transformed intensities, q-values from Benjamini-Hochberg adjustment of these, and p-values for each line from Tukey’s Honest Significant Difference <i>post hoc</i> comparison to wild-type.
DOI: 10.6084/m9.figshare.10059779.v1
title: Sharp Bounds on Functionals of the Joint Distribution in the Analysis of Treatment Effects

description: This paper proposes an identification and estimation method that allows researchers to bound continuous functionals of the joint distribution of potential outcomes from the literature on treatment effects. The focus is on a model where no restrictions are imposed on treatment selection. The method can sharply bound interesting parameters when analytical bounds are difficult to derive, can be used in settings in which instruments are available, and can easily accommodate additional model constraints. However, computational considerations for the method are found to be important, and are discussed in detail.
DOI: 10.6084/m9.figshare.10059644
title: Ab42 13.7uM + Ab42 seed pH 6.8 12 min

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated with 1.4 µM premade Ab42 fibrils for 10 min in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059632
title: Ab40 13.7uM + Ab40 seed pH 6.8 2h

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated with 1.4 µM premade Ab40 fibrils for 2h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059644.v1
title: Ab42 13.7uM + Ab42 seed pH 6.8 12 min

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated with 1.4 µM premade Ab42 fibrils for 10 min in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059668
title: Ab42 13.7uM + trAb42 seed pH 6.8 12 min

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated with 1.4 µM premade Ab42 fibrils, treated with endoprotease GluC, for 10 min in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059620
title: Ab40 13.7uM + Ab42 seed pH 6.8 2h

description: Amyloid beta M(1-40) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated with 1.4 µM premade Ab42 fibrils for 2h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059668.v1
title: Ab42 13.7uM + trAb42 seed pH 6.8 12 min

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated with 1.4 µM premade Ab42 fibrils, treated with endoprotease GluC, for 10 min in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059620.v1
title: Ab40 13.7uM + Ab42 seed pH 6.8 2h

description: Amyloid beta M(1-40) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated with 1.4 µM premade Ab42 fibrils for 2h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059632.v1
title: Ab40 13.7uM + Ab40 seed pH 6.8 2h

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated with 1.4 µM premade Ab40 fibrils for 2h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059611
title: Ab42 13.7uM + Ab40 seed pH 6.8 2h

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated with 1.4 µM premade Ab40 fibrils for 2h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059605
title: Ab42 13.7uM + Ab42 seed pH 6.8 2h

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated with 1.4 µM premade Ab42 fibrils for 2h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059611.v1
title: Ab42 13.7uM + Ab40 seed pH 6.8 2h

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated with 1.4 µM premade Ab40 fibrils for 2h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059575
title: Ab42 13.7uM pH 6.8 2h

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated for 2h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059575.v1
title: Ab42 13.7uM pH 6.8 2h

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated for 2h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059596
title: Ab42 13.7µM + Brichos 13.7 µM pH 6.8 20h

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated with 13.7 µM pro-SPC-Brichos for 20h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059605.v1
title: Ab42 13.7uM + Ab42 seed pH 6.8 2h

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated with 1.4 µM premade Ab42 fibrils for 2h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059551
title: Metadata record for: Global hydro-environmental sub-basin and river reach characteristics at high spatial resolution

description: This dataset contains key characteristics about the data described in the Data Descriptor Global hydro-environmental sub-basin and river reach characteristics at high spatial resolution. <br> Contents: <br> 1. human readable metadata summary table in CSV format 2. machine readable metadata file in JSON format <br> <br> Versioning Note:Version 2 was generated when the metadata format was updated from JSON to JSON-LD. This was an automatic process that changed only the format, not the contents, of the metadata.<br>
DOI: 10.6084/m9.figshare.10059596.v1
title: Ab42 13.7µM + Brichos 13.7 µM pH 6.8 20h

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated with 13.7 µM pro-SPC-Brichos for 20h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059563
title: Ab42 13.7uM pH 6.8 5h

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated for 5h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059563.v1
title: Ab42 13.7uM pH 6.8 5h

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated for 5h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059551.v2
title: Metadata record for: Global hydro-environmental sub-basin and river reach characteristics at high spatial resolution

description: This dataset contains key characteristics about the data described in the Data Descriptor Global hydro-environmental sub-basin and river reach characteristics at high spatial resolution. <br> Contents: <br> 1. human readable metadata summary table in CSV format 2. machine readable metadata file in JSON format <br> <br> Versioning Note:Version 2 was generated when the metadata format was updated from JSON to JSON-LD. This was an automatic process that changed only the format, not the contents, of the metadata.<br>
DOI: 10.6084/m9.figshare.10059551.v1
title: Metadata record for: Global hydro-environmental sub-basin and river reach characteristics at high spatial resolution

description: This dataset contains key characteristics about the data described in the Data Descriptor Global hydro-environmental sub-basin and river reach characteristics at high spatial resolution. <br> Contents: <br> 1. human readable metadata summary table in CSV format 2. machine readable metadata file in JSON format
DOI: 10.6084/m9.figshare.10059413
title: Supplementary Material for: Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE

description: <b><i>Background:</i></b> Sodium zirconium cyclosilicate (SZC; formerly ZS-9) is a selective potassium (K<sup>+</sup>) binder for treatment of hyperkalemia. An open-label extension (OLE) of the ­HARMONIZE study evaluated efficacy and safety of SZC for ≤11 months. <b><i>Methods:</i></b> Patients from HARMONIZE with point-of-care device i-STAT K<sup>+</sup> 3.5–6.2 mmol/L received once-daily SZC 5–10 g for ≤337 days. End points included achievement of mean serum K<sup>+</sup> ≤5.1 mmol/L (primary) or ≤5.5 mmol/L (secondary). <b><i>Results:</i></b> Of 123 patients who entered the extension (mean serum K<sup>+</sup> 4.8 mmol/L), 79 (64.2%) completed the study. The median daily dose of SZC was 10 g (range 2.5–15 g). The primary end point was achieved by 88.3% of patients, and 100% achieved the secondary end point. SZC was well tolerated with no new safety concerns. <b><i>Conclusion:</i></b> In the HARMONIZE OLE, most patients maintained mean serum K<sup>+</sup> within the normokalemic range for ≤11 months during ongoing SZC treatment.
DOI: 10.6084/m9.figshare.10059413.v1
title: Supplementary Material for: Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE

description: <b><i>Background:</i></b> Sodium zirconium cyclosilicate (SZC; formerly ZS-9) is a selective potassium (K<sup>+</sup>) binder for treatment of hyperkalemia. An open-label extension (OLE) of the ­HARMONIZE study evaluated efficacy and safety of SZC for ≤11 months. <b><i>Methods:</i></b> Patients from HARMONIZE with point-of-care device i-STAT K<sup>+</sup> 3.5–6.2 mmol/L received once-daily SZC 5–10 g for ≤337 days. End points included achievement of mean serum K<sup>+</sup> ≤5.1 mmol/L (primary) or ≤5.5 mmol/L (secondary). <b><i>Results:</i></b> Of 123 patients who entered the extension (mean serum K<sup>+</sup> 4.8 mmol/L), 79 (64.2%) completed the study. The median daily dose of SZC was 10 g (range 2.5–15 g). The primary end point was achieved by 88.3% of patients, and 100% achieved the secondary end point. SZC was well tolerated with no new safety concerns. <b><i>Conclusion:</i></b> In the HARMONIZE OLE, most patients maintained mean serum K<sup>+</sup> within the normokalemic range for ≤11 months during ongoing SZC treatment.
DOI: 10.6084/m9.figshare.10059287
title: Ab42 13.7uM pH 6.8 30h

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated for 30h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059296
title: Ab42 13.7uM pH 6.8 9h

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated for 9h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059302
title: Ab42 13.7uM pH 6.8 33h

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated for 33h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059287.v1
title: Ab42 13.7uM pH 6.8 30h

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated for 30h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059296.v1
title: Ab42 13.7uM pH 6.8 9h

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated for 9h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059281
title: Ab42 13.7uM pH 6.8 10h

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated for 10h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059302.v1
title: Ab42 13.7uM pH 6.8 33h

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated for 33h in quartz NMR tube before being withdrawn for freezing and imaging.
DOI: 10.6084/m9.figshare.10059281.v1
title: Ab42 13.7uM pH 6.8 10h

description: Amyloid beta M(1-42) 13.7 µM in 20 mM phosphate buffer pH 6.8. Incubated for 10h in quartz NMR tube before being withdrawn for freezing and imaging.